Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Dow
Moodys
Boehringer Ingelheim
Mallinckrodt

Last Updated: May 28, 2022

CAROSPIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Carospir, and when can generic versions of Carospir launch?

Carospir is a drug marketed by Cmp Dev Llc and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has four patent family members in four countries.

The generic ingredient in CAROSPIR is spironolactone. There are sixteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the spironolactone profile page.

Drug patent expirations by year for CAROSPIR
Drug Prices for CAROSPIR

See drug prices for CAROSPIR

Recent Clinical Trials for CAROSPIR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 2

See all CAROSPIR clinical trials

Pharmacology for CAROSPIR
Paragraph IV (Patent) Challenges for CAROSPIR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CAROSPIR Oral Suspension spironolactone 25 mg/5 mL 209478 1 2020-12-31

US Patents and Regulatory Information for CAROSPIR

CAROSPIR is protected by five US patents.

Patents protecting CAROSPIR

Spironolactone aqueous compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Spironolactone aqueous compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Spironolactone aqueous compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Spironolactone aqueous compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Spironolactone aqueous formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: CAROSPIR IS INDICATED FOR TREATMENT OF NYHA CLASS III-IV HEART FAILURE AND REDUCED EJECTION FRACTION TO INCREASE SURVIVAL, MANAGE EDEMA, AND TO REDUCE THE NEED FOR HOSPITALIZATION FOR HEART FAILURE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cmp Dev Llc CAROSPIR spironolactone SUSPENSION;ORAL 209478-001 Aug 4, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CAROSPIR

See the table below for patents covering CAROSPIR around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 3368045 COMPOSITIONS AQUEUSES DE SPIRONOLACTONE (SPIRONOLACTONE AQUEOUS COMPOSITIONS) See Plans and Pricing
Morocco 43132 COMPOSITIONS AQUEUSES DE SPIRONOLACTONE See Plans and Pricing
Canada 3003028 COMPOSITIONS AQUEUSES DE SPIRONOLACTONE (SPIRONOLACTONE AQUEOUS COMPOSITIONS) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2017075463 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Dow
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.